- Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure
- Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: Results from a multicenter study
- Impact of continuous regional arterial infusion in the treatment of acute necrotizing pancreatitis: Analysis of a national administrative database
- Are non-pharmacologic pain interventions effective at reducing pain in adult patients visiting the Emergency Department? A systematic review and meta-analysis
- Concurrent veliparib with chest wall and nodal radiotherapy in patients with inflammatory or locoregionally recurrent breast cancer: The TBCRC 024 phase I multicenter study
- Is the use of dexamethasone effective in controlling pain associated with symptomatic irreversible pulpitis? a systematic review
- Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose
- Omalizumab for the treatment of solar urticaria: Case series and systematic review of the literature
- Long-term use of valproic acid and the prevalence of cancers in bipolar disorder patients in a Taiwanese population: An association analysis using the National Health Insurance Research Database (NHIRD)
- Effect of fenofibrate on uric acid and gout in type 2 diabetes: A post-hoc analysis of the randomised, controlled FIELD study
- Semaglutide vs dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
- Clinical response to Nabiximols correlates with the down-regulation of immune pathways in multiple sclerosis
- Mycophenolate plus methylprednisolone vs methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): A randomised, observer-masked, multicentre trial
- Cost of achieving HbA1c treatment targets and weight loss responses with once-weekly semaglutide vs dulaglutide in the United States
Feed Sources
